A.I. is critical to the growth of healthcare in the coming decade. It needs to be managed correctly and urgent ethical guidelines regulating its use need to be implimented.
Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics